Invests in categories: BioTechCommerceDevelopmentFutureHealthTechManufacturingMedTechProductResearchService
Portfolio 8
Mentions in press and media 2
| Date | Title | Description |
| 22.03.2016 | S Korean biotech firm Sillajen raises $12m from Medivate Partners | Premium
Sillajen, a South Korea-based oncolytic immunotherapeutic startup, has raised $12 million funding from Medivate Partners, a private equity and venture capital firm investing in Asia and North America biotech and healthcare industry.... |
| 21.03.2016 | Sillajen Raises $12M in Funding | Sillajen, a Seoul, South Korea-based global oncolytic immunotherapeutic company, raised $12m in funding.
Medivate Partners made the investment. In conjunction with the funding, Mr. Paul Kim, CEO & Managing Partner of Medivate Partners, ... |
Reviews 0